Sionna Therapeutics, Inc. (NASDAQ: SION) is a Healthcare company (Biotechnology) with a market capitalization of $139M. The Maz Rating grades it against the other companies in its sector.
Sionna Therapeutics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.07, Sionna Therapeutics, Inc. trades at 0.6x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -39.8%, return on invested capital of -46.0% and a free cash flow yield of -73.1%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 13.92. Over the past 52 weeks the share price ranged from $2.99 to $54.97, with a beta of 1.22.
Sionna Therapeutics, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 3 Buy, 4 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.